Allied Healthcare Products, Inc.Find Ratings Reports
ALLIED HEALTHCARE PRODS INC's gross profit margin for the first quarter of its fiscal year 2021 has increased when compared to the same period a year ago. The company grew its sales and net income significantly quarter versus same quarter a year prior, and was able to outpace the average competitor in the subsector when comparing revenue growth, but not when comparing net income growth. ALLIED HEALTHCARE PRODS INC has very weak liquidity. Currently, the Quick Ratio is 0.33 which clearly shows a lack of ability to cover short-term cash needs. The liquidity decreased from the same period a year ago, despite already having weak liquidity to begin with. This would indicate deteriorating cash flow.
During the same period, stockholders' equity ("net worth") has decreased by 22.62% from the same quarter last year. The key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY21||Q1 FY20|
|Net Sales ($mil)||10.19||7.98|
|Net Income ($mil)||-0.15||-0.61|
|Balance Sheet||Q1 FY21||Q1 FY20|
|Cash & Equiv. ($mil)||0.01||0.3|
|Total Assets ($mil)||19.69||15.48|
|Total Debt ($mil)||3.6||0.85|
|Profitability||Q1 FY21||Q1 FY20|
|Gross Profit Margin||20.01||18.07|
|Return on Assets||-12.96||-9.61|
|Return on Equity||-29.26||-13.2|
|Debt||Q1 FY21||Q1 FY20|
|Share Data||Q1 FY21||Q1 FY20|
|Shares outstanding (mil)||4.01||4.01|
|Div / share||0.0||0.0|
|Book value / share||2.17||2.81|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||499062.0||270828.0|
SELL. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. For additional comparison, its price-to-book ratio of 2.50 indicates a significant discount versus the S&P 500 average of 4.02 and a significant discount versus the subsector average of 10.30. The price-to-sales ratio is well below both the S&P 500 average and the subsector average, indicating a discount. After reviewing these and other key valuation criteria, ALLIED HEALTHCARE PRODS INC proves to trade at a discount to investment alternatives.
|AHPI NM||Peers 81.85||AHPI NM||Peers 49.47|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
AHPI's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
AHPI's P/CF is negative making the measure meaningless.
|AHPI NA||Peers 70.51||AHPI NA||Peers 3.46|
Neutral. A lower price-to-projected earnings ratio than its peers can signify a less expensive stock or lower future growth potential.
Ratio not available.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|AHPI 2.50||Peers 10.30||AHPI -72.97||Peers 20.69|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
AHPI is trading at a significant discount to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, AHPI is expected to significantly trail its peers on the basis of its earnings growth rate.
|AHPI 0.64||Peers 12.14||AHPI 6.29||Peers 17.36|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
AHPI is trading at a significant discount to its subsector on this measurement.
Lower. A sales growth rate that trails the subsector implies that a company is losing market share.
AHPI significantly trails its peers on the basis of sales growth.